MET
MetLife, Inc.
NYSE · Financial Services · Insurance - Life · US
$97.62
−1.62%Year over year
Reported trailing growth
- Revenue
- +9.0%
- EBITDA
- -11.7%
- EBIT
- -14.7%
- EPS
- -11.6%
- Free cash flow
- +5.2%
- Operating cash flow
- +5.2%
Forward estimates
Based on analyst estimates
- Revenue
- +4.9%
- EBITDA
- +54.7%
- EPS
- +100.9%
Three-year CAGR
- Revenue
- +4.3%
- EBITDA
- -6.7%
- EBIT
- -9.9%
- Net income
- -13.8%
- EPS
- -8.9%
- Free cash flow
- +16.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026